Discovery | for NHS Organisations
NHS patient data is one of the world’s largest and most valuable datasets from an integrated healthcare system covering 65 million people in the UK.  This data represents a sovereign asset, but it is not yet being leveraged to a meaningful extent - to improve care and accelerate medical research. We want to help change that.

How we work

Our collaborative model sees individual NHS organisations retaining full control of their data under the SRA agreements. Analysis by Sensyne Health is:

Discovery

Discovery and development of new insights or therapeutic targets

NHS approved

Pre-approved on a case-by-case basis by the relevant NHS organisations

Patient Data

Undertaken only on patient data that has been anonymised

Our approach: creating value from the analysis of patient data

Drug development stages diagram
Drug development stages diagram

Comprehensive analyse of this anonymised data using AI has the potential to improve patient care, accelerate the discovery of new medicines, better understand and treat disease, and reduce costs.  Sensyne Health collaborates with NHS Trusts under strategic research agreements to combine clinical artificial intelligence with ethically-sourced, anonymised patient data to advance medical research.

Find out more about Strategic Research Agreements

How the NHS benefits

Through sharing ethically sourced anonymised data our NHS partners benefit:

Access to clinically led expertise in machine learning team
Access to clinically led expertise in machine learning team
Structured, curated, contextualised data
Structured, curated, contextualised data
Data analysis to answer key NHS questions in medical research, patient care and operational efficiency
Data analysis to answer key NHS questions in medical research, patient care and operational efficiency
a link between the life sciences industry and clinicians
A link between the life sciences industry and clinicians
Take an economic interest in the pharmaceutical product
Value and a financial return

Comprehensive analyse of this anonymised data using AI has the potential to improve patient care, accelerate the discovery of new medicines, better understand and treat disease, and reduce costs.  Sensyne Health collaborates with NHS Trusts under strategic research agreements to combine clinical artificial intelligence with ethically-sourced, anonymised patient data to advance medical research.

See how we improve patient care
This partnership approach, which is unique in the UK, is designed to ensure that the NHS, individual Trusts and their patients benefit from NHS data.  The NHS Trusts we work with own an equity stake in Sensyne Health and are entitled to receive a share of any revenues generated by Sensyne Health as a result of the commercialisation of research carried out.

Through our NHS partnerships, and under a rigorous information governance framework, we have access to large quantities of rich, anonymised patient data. This includes information on prescriptions, diagnoses, imaging, pathology and outcomes.  When combined with our proprietary AI methods, we can uncover a hidden collective context in the data and provide actionable research insights, then file patents to protect them.

We work closely with leading clinicians in our partner Trusts to understand the patient journey on a clinical pathway, and how the different data sets available within each Trust link to these pathways. This enables us to contextualise specific research questions and understand how the different data sets can be optimally used to provide solutions that support our projects. We also work with our partner Trusts to support work on operational efficiency within the NHS.

Partner with us

Like to hear more about how we partner with NHS trusts and understand how we could partner with you?

Contact us